Creative Medical Technology Holdings financials
$0.9652−4.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K |
| Gross profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K |
| Gross margin | 63.4% | 60.0% | 60.0% | 67.8% | 45.4% |
| Operating income | -$6.1M | -$5.7M | -$5.6M | -$10.2M | -$3.1M |
| Net income | -$6.0M | -$5.5M | -$5.3M | -$10.1M | $19.2M |
| Net margin | −99916.8% | −49940.7% | −58739.7% | −11449.3% | 21892.8% |
| Diluted EPS | $-2.52 | $-3.71 | $-3.76 | $-9.28 | $56.10 |
| EBITDA | -$6.0M | -$5.6M | -$5.5M | -$10.2M | -$3.0M |
| Operating cash flow | -$5.9M | -$5.3M | -$8.0M | -$7.8M | -$2.2M |
| Free cash flow | -$5.9M | -$5.3M | -$8.0M | -$7.8M | — |
| Diluted shares | 2.4M | 1.5M | 1.4M | 1.1M | 0.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $7.2M | $5.9M | $3.5M | $8.3M | $10.7M |
| Short-term investments | $0.00 | $0.00 | $6.5M | $10.1M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $7.8M | $6.7M | $10.7M | $19.2M | $11.3M |
| Total liabilities | $284.9K | $327.6K | $371.4K | $3.3M | $1.1M |
| Shareholders' equity | $7.5M | $6.3M | $10.3M | $15.9M | $10.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology